Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.71 USD | +0.65% | +4.05% | +185.56% |
May. 15 | Eliem Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 11 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Business Summary
Number of employees: 10
Managers
Managers | Title | Age | Since |
---|---|---|---|
Valerie Morisset
FOU | Founder | 55 | 18-10-17 |
Andrew Levin
CEO | Chief Executive Officer | 47 | 18-10-17 |
Emily Pimblett
AUD | Comptroller/Controller/Auditor | 40 | 21-02-28 |
Joanne Palmer
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Liam Ratcliffe
BRD | Director/Board Member | 60 | 19-09-30 |
Adam Rosenberg
BRD | Director/Board Member | 54 | 20-09-30 |
Andrew Levin
CEO | Chief Executive Officer | 47 | 18-10-17 |
Simon Tate
BRD | Director/Board Member | 58 | 19-01-31 |
Judith Dunn
BRD | Director/Board Member | 62 | 21-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,091,166 | 21,766,139 ( 74.82 %) | 0 | 74.82 % |
Company contact information
Eliem Therapeutics, Inc.
2801 Centerville Road 1st Floor
19808-1609, Wilmington
+
http://www.eliemtx.comSector
1st Jan change | Capi. | |
---|---|---|
+185.56% | 224M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ELYM Stock
- Company Eliem Therapeutics, Inc.